To include your compound in the COVID-19 Resource Center, submit it here.

EMA publishes follow-up guidelines for ATMPs

EMA released revised guidelines on safety and efficacy follow-up and risk management of advanced therapy medicinal products (ATMPs), which include therapies made from genes, tissue or cells. The guidelines include procedures to enable

Read the full 335 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE